The geographic atrophy GA market growth trajectory reflects the convergence of scientific breakthroughs, regulatory progress, and demographic imperatives that are collectively transforming outcomes for patients with advanced dry age-related macular degeneration. This market expansion is propelled by the transition from a therapeutic void to an evolving treatment landscape featuring...